High-dose chemotherapy in adult soft tissue sarcomaREICHARDT, Peter.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 157-167, issn 1040-8428Article

The role of high-dose chemotherapy in the treatment of non-small cell lung cancerFETSCHER, Sebastian.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 151-156, issn 1040-8428Article

The future development of bevacizumab in colorectal cancerDIAZ-RUBIO, Eduardo; SCHMOLL, Hans-Joachim.Oncology. 2005, Vol 69, pp 34-45, issn 0030-2414, 12 p., SUP3Article

Tumor cell contamination in re-infused stem cell autografts : Does it have clinical significance?SHIMONI, Avichai; KÖRBLING, Martin.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 241-250, issn 1040-8428Article

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT)BURDACH, S; JÜRGENS, H.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 169-189, issn 1040-8428Article

Adjuvant Therapy for Early Colon Cancer: Current StatusSTEIN, Alexander; HIEMER, Sonja; SCHMOLL, Hans-Joachim et al.Drugs (Basel). 2011, Vol 71, Num 17, pp 2257-2275, issn 0012-6667, 19 p.Article

Critical role of anti-angiogenesis and VEGF inhibition in colorectal cancerDIAZ-RUBIO, Eduardo; SCHMOLL, Hans-Joachim.Oncology. 2005, Vol 69, issn 0030-2414, 59 p., SUP3Serial Issue

Economic aspects of high-dose chemotherapy: a clinician's perspective reviewCETTO, Gian Luigi; MOLINO, Annamaria.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 251-267, issn 1040-8428Article

Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinomaSAAD, Everardo D; ABBRUZZESE, James L.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 205-211, issn 1040-8428Article

Human hematopoietic growth factors : Old lessons and new perspectivesDEMPKE, Wolfram; VON POBLOZKI, Almut; GROTHEY, Axel et al.Anticancer research. 2000, Vol 20, Num 6D, pp 5155-5164, issn 0250-7005Article

Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancerHURWITZ, Herbert; KABBINAVAR, Fairooz.Oncology. 2005, Vol 69, pp 17-24, issn 0030-2414, 8 p., SUP3Article

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatmentGROTHEY, Axel; SARGENT, Daniel; GOLDBERG, Richard M et al.Journal of clinical oncology. 2004, Vol 22, Num 7, pp 1209-1214, issn 0732-183X, 6 p.Article

High-dose therapy for indolent lymphomaMOUNIER, Nicolas; SOCIE, Gérard; GISSELBRECHT, Christian et al.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 225-239, issn 1040-8428Article

A low dose of ionizing radiation increases luminal release of intestinal peptidases in ratsFITTKAU, Marina; GROTHEY, Axel; GERLACH, Reinhard et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 2, pp 96-100, issn 0171-5216Article

High-dose chemotherapy with autologous stem cell rescue for brain tumorsDUNKEL, Ira J; FINLAY, Jonathan L.Critical reviews in oncology/hematology. 2002, Vol 41, Num 2, pp 197-204, issn 1040-8428Article

Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors : Result of an update conference on Evidence-Based Medicine (EBM)KREGE, Susanne; SOUCHON, Rainer; SCHMOLL, Hans-Joachim et al.European urology. 2001, Vol 40, Num 4, pp 372-391, issn 0302-2838Article

Investigating the potential of bevacizumab in other indications : Metastatic renal cell, non- small cell lung, pancreatic and breast cancerDE GRAMONT, Aimery; VAN CUTSEM, Eric.Oncology. 2005, Vol 69, pp 46-56, issn 0030-2414, 11 p., SUP3Article

Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancerPREISS, J.Seminars in oncology. 1992, Vol 19, Num 2, pp 220-224, issn 0093-7754, SUP3Conference Paper

Recent developments in biomodulationSCHMOLL, Hans-Joachim; HIDDEMANN, Wolfgang; RUSTUM, Yussef et al.Seminars in oncology. 1992, Vol 19, Num 2, issn 0093-7754, SUP3Conference Proceedings

Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapyJORDAN, Karin; KINITZ, Iris; VOIGT, Wieland et al.European journal of cancer (1990). 2009, Vol 45, Num 7, pp 1184-1187, issn 0959-8049, 4 p.Article

Review of regional therapy of liver metastases in colorectal cancerKEMENY, N.Seminars in oncology. 1992, Vol 19, Num 2, pp 155-162, issn 0093-7754, SUP3Conference Paper

Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancerRÖDEL, Claus; GERHARD; GRABENBAUER, G et al.Journal of clinical oncology. 2003, Vol 21, Num 16, pp 3098-3104, issn 0732-183X, 7 p.Article

Advanced Seminoma and Nonseminoma: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009SCHMOLL, Hans-Joachim; OSANTO, Susanne; KAWAI, Koji et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 4A, issn 0090-4295, S456-S468, SUPArticle

Biochemical modulation of fluorouracil by dipyridamole : preclinical and clinical experienceGREM, J. L.Seminars in oncology. 1992, Vol 19, Num 2, pp 56-65, issn 0093-7754, SUP3Conference Paper

Roundtable discussion : second international workshop on gastrointestinal cancer, recent developments in biomodulationWADLER, S; SCHMOLL, H.-J.Seminars in oncology. 1992, Vol 19, Num 2, pp 234-235, issn 0093-7754, SUP3Conference Paper